Macrophages: an elusive yet emerging therapeutic target of atherosclerosis

RL Tiwari, V Singh, MK Barthwal - Medicinal research reviews, 2008 - Wiley Online Library
Macrophages are central to the initiation and progression of atherosclerosis and thus can be
very appropriate targets for therapy. Cell adhesion molecules mediating monocytes …

Inflammatory mediators in atherosclerotic vascular disease

A Zernecke, C Weber - Basic research in cardiology, 2005 - Springer
An impressive body of work has established the current paradigm of atherosclerosis as an
inflammatory process that promotes lesion development and progression. Early atheroma …

Inflammation in coronary atherosclerosis and its therapeutic implications

NJ Montarello, MT Nguyen, DTL Wong… - … drugs and therapy, 2022 - Springer
Atherosclerotic coronary artery disease has a complex pathogenesis which extends beyond
cholesterol intimal infiltration. It involves chronic inflammation of the coronary artery wall …

The biological role of inflammation in atherosclerosis

BW Wong, A Meredith, D Lin, BM McManus - Canadian Journal of …, 2012 - Elsevier
The concept of the involvement of inflammation in the pathogenesis of atherosclerosis has
existed since the 1800s, stemming from sentinel pathologic observations made by Rudolf …

Anti-inflammatory therapies for cardiovascular disease

PM Ridker, TF Lüscher - European heart journal, 2014 - academic.oup.com
Atherothrombosis is no longer considered solely a disorder of lipoprotein accumulation in
the arterial wall. Rather, the initiation and progression of atherosclerotic lesions is currently …

Contribution of vascular cell‐derived cytokines to innate and inflammatory pathways in atherogenesis

H Loppnow, M Buerke, K Werdan… - Journal of cellular and …, 2011 - Wiley Online Library
Introduction• Atherosclerosis‐overview‐General remarks‐Early atherosclerosis‐Exogenous
and/or infectious activators‐Endogenous activators‐Later phases of atherosclerosis• Innate …

[HTML][HTML] The impact of cytokines in coronary atherosclerotic plaque: current therapeutic approaches

P Tsioufis, P Theofilis, K Tsioufis… - International Journal of …, 2022 - mdpi.com
Coronary atherosclerosis is a chronic pathological process that involves inflammation
together with endothelial dysfunction and lipoprotein dysregulation. Experimental studies …

Targeting T cells to treat atherosclerosis: odyssey from bench to bedside

J Bullenkamp, S Dinkla, JC Kaski… - European Heart …, 2016 - academic.oup.com
More than 150 years from the initial description of inflammation in atherosclerotic plaques,
randomized clinical trials to test anti-inflammatory therapies in atherosclerosis have recently …

[HTML][HTML] Inflammation and atherosclerosis: signaling pathways and therapeutic intervention

P Kong, ZY Cui, XF Huang, DD Zhang… - Signal transduction and …, 2022 - nature.com
Atherosclerosis is a chronic inflammatory vascular disease driven by traditional and
nontraditional risk factors. Genome-wide association combined with clonal lineage tracing …

Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation

S Kofler, T Nickel, M Weis - Clinical science, 2005 - portlandpress.com
Complex cellular and inflammatory interactions are involved in the progress of vascular
diseases. Endothelial cells, upon exposure to cytokines, undergo profound alterations of …